Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Sirolimus Albumin-bound Nanoparticles

Review the clinical trials studying sirolimus albumin-bound nanoparticles on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-3 of 3

Nab-Sirolimus and Fulvestrant for the Treatment of Recurrent Low Grade Serous Ovarian Cancer
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Gemcitabine and Nab-Sirolimus for the Treatment of Patients with Advanced Leiomyosarcomas or Soft-Tissue Sarcomas with TSC2 or TSC1 Loss-of-Function Mutations or Deletions
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Status: Active
Location: 2 locations